BNP PARIBAS

Position in MRK — Merck & Co., Inc.

CIK 872786 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$9,605,503

+$565,711 QoQ

Shares Held

74,751

-0.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#757

of 3,769 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BNP PARIBAS holds $145,518,414 across 9 Drug Manufacturers - General names. MRK ranks #7 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	38,251	$45,879,399
2	ABBV	AbbVie Inc.	79,596	$20,029,536
3	PFE	Pfizer Inc	810,791	$19,523,846
4	AMGN	Amgen Inc	44,979	$16,287,794
5	GILD	Gilead Sciences, Inc.	118,671	$14,992,893
6	JNJ	Johnson & Johnson	44,551	$11,314,616
7	MRK	Merck & Co., Inc. This page	74,751	$9,605,503
8	BMY	Bristol Myers Squibb Co	120,493	$6,942,806

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,605,503	74,751	-0.5%	Shares	Defined	2026-08-13
2026-03-31	$9,039,792	75,150	+3.6%	Shares	Defined	2026-05-12
2025-12-31	$7,634,611	72,531	-19.5%	Shares	Defined	2026-02-10
2025-09-30	$7,559,825	90,073	-4.5%	Shares	Defined	2025-11-14
2025-06-30	$7,462,808	94,275	-27.5%	Shares	Defined	2025-08-14
2025-03-31	$11,674,722	130,066	-60.7%	Shares	Defined	2025-05-15
2024-12-31	$32,895,348	330,673	+3.4%	Shares	Defined	2025-02-14
2024-09-30	$36,312,171	319,762	+2.9%	Shares	Defined	2024-11-13
2024-06-30	$38,484,590	310,861	-1.2%	Shares	Defined	2024-08-13
2024-03-31	$41,507,905	314,573	—	Shares	Defined	2024-05-02
No filing history on record for this holder in this stock.